Thank you for sharing!

Your article was successfully shared with the contacts you provided.

As Pfizer considered changing its business mix, the $67.8 billion pharmaceutical maker wanted to get a better handle on the best capital structure for the company. So treasury built a dynamic model that takes into account Pfizer’s balance sheet and cash flow forecasts to determine an appropriate capital structure.

Treasury & Risk

Join Treasury & Risk

Don’t miss crucial treasury and finance news along with in-depth analysis and insights you need to make informed treasury decisions. Join Treasury & Risk now!

  • Free unlimited access to Treasury & Risk including case studies with corporate innovators, informative newsletters, educational webcasts, and resources from industry leaders.
  • Exclusive discounts on ALM and Treasury & Risk events.
  • Access to other award-winning ALM publications including PropertyCasualty360.com and Law.com.

Already have an account? Sign In Now
Join Treasury & Risk

Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.